Shandong Weigao Group Medical Polymer Co Ltd Class H (HK:1066)
:1066
Want to see HK:1066 full AI Analyst Report?
1066 Stock Chart & Stats
HK$5.55
HK$0.12(2.84%)
At close: 4:00 PM EST
HK$5.55
HK$0.12(2.84%)
Day’s Range― - ―
52-Week RangeHK$3.39 - HK$7.39
Previous CloseN/A
Volume8.70M
Average Volume (3M)10.92M
Market Cap
HK$15.65B
Enterprise ValueHK$10.60B
Total Cash (Recent Filing)HK$9.87B
Total Debt (Recent Filing)HK$5.99B
Price to Earnings (P/E)12.9
Beta1.13
Next Earnings
Sep 02, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend Yield4.58%
Share Statistics
EPS (TTM)0.35
Shares Outstanding4,522,332,500
10 Day Avg. Volume7,849,305
30 Day Avg. Volume10,915,466
Financial Highlights & Ratios
PEG Ratio-0.54
Price to Book (P/B)0.86
Price to Sales (P/S)1.55
P/FCF Ratio12.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.62Price Target Upside1.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.38
Revenue Forecast (FY)HK$14.19B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA low, stable debt-to-equity ratio and expanding equity base provide lasting financial resilience. This reduces refinancing and liquidity risk, preserves strategic optionality for capex or M&A, and supports operations through industry cycles over the next several quarters.
Positive Cash GenerationConsistent positive operating and free cash flow, despite a recent decline, underpins the company's ability to fund operations, dividends and necessary investments without heavy external financing. This structural cash generation supports medium-term stability and strategic choices.
Recurring Demand For DisposablesFocus on hospital consumables creates recurring, predictable revenue driven by routine clinical use. The consumables business model typically yields steady demand and repeat purchasing, insulating revenue from single-product swings and supporting mid-term cash visibility.
Bears Say
Sharp Recent Revenue DeclineA 40% revenue drop materially erodes scale and operating leverage, weakening long-term earnings power. Sustained top-line contraction can impair R&D and manufacturing efficiency, complicate customer retention, and pressure medium-term profitability and investment plans.
Margin CompressionMaterial margin deterioration reduces cash available for reinvestment and returns. Persistent compression signals pricing, cost, or mix pressures that could be structural, limiting ability to restore prior profit levels and constraining long-term operating flexibility.
Weakened Return On EquityA halving of ROE over several years indicates declining capital efficiency and weaker profitability per unit of equity. If persistent, lower ROE reduces shareholder return prospects and could reflect competitive erosion or an inability to translate assets into sustainable earnings.
Shandong Weigao Group Medical Polymer Co News
1066 FAQ
What was Shandong Weigao Group Medical Polymer Co Ltd Class H’s price range in the past 12 months?
Shandong Weigao Group Medical Polymer Co Ltd Class H lowest stock price was HK$3.39 and its highest was HK$7.39 in the past 12 months.
What is Shandong Weigao Group Medical Polymer Co Ltd Class H’s market cap?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s market cap is HK$15.65B.
When is Shandong Weigao Group Medical Polymer Co Ltd Class H’s upcoming earnings report date?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s upcoming earnings report date is Sep 02, 2026 which is in 103 days.
How were Shandong Weigao Group Medical Polymer Co Ltd Class H’s earnings last quarter?
Shandong Weigao Group Medical Polymer Co Ltd Class H released its earnings results on Mar 27, 2026. The company reported HK$0.149 earnings per share for the quarter, missing the consensus estimate of HK$0.206 by -HK$0.057.
Is Shandong Weigao Group Medical Polymer Co Ltd Class H overvalued?
According to Wall Street analysts Shandong Weigao Group Medical Polymer Co Ltd Class H’s price is currently Undervalued.
Does Shandong Weigao Group Medical Polymer Co Ltd Class H pay dividends?
Shandong Weigao Group Medical Polymer Co Ltd Class H pays a Notavailable dividend of HK$0.106 which represents an annual dividend yield of 4.58%. See more information on Shandong Weigao Group Medical Polymer Co Ltd Class H dividends here
What is Shandong Weigao Group Medical Polymer Co Ltd Class H’s EPS estimate?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s EPS estimate is 0.23.
How many shares outstanding does Shandong Weigao Group Medical Polymer Co Ltd Class H have?
Shandong Weigao Group Medical Polymer Co Ltd Class H has 4,522,332,500 shares outstanding.
What happened to Shandong Weigao Group Medical Polymer Co Ltd Class H’s price movement after its last earnings report?
Shandong Weigao Group Medical Polymer Co Ltd Class H reported an EPS of HK$0.149 in its last earnings report, missing expectations of HK$0.206. Following the earnings report the stock price went up 3.153%.
Which hedge fund is a major shareholder of Shandong Weigao Group Medical Polymer Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:1066
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shandong Weigao Group Medical Polymer Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.57%
12-Months-Change
Fundamentals
Return on Equity
6.64%
Trailing 12-Months
Asset Growth
8.32%
Trailing 12-Months
Company Description
Shandong Weigao Group Medical Polymer Co Ltd Class H
Shandong Weigao Group Medical Polymer Co., Ltd. is a leading Chinese manufacturer specializing in the production of medical devices and polymer products. Established in 1992, the company operates primarily in the healthcare sector, offering a diverse range of products including intravenous (IV) systems, infusion pumps, and other medical consumables. Weigao is recognized for its commitment to innovation and quality, serving hospitals and healthcare providers both domestically and internationally.
1066 Stock 12 Month Forecast
Average Price Target
HK$5.62
▲(1.26% Upside)
Technical Analysis
PW Medtech Group Ltd.
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―
Options Prices
Currently, No data available
---